Eloxx Pharmaceuticals Inc (OTCQB:ELOX)

6.75
Delayed Data
As of 2:21pm ET
 -0.05 / -0.74%
Today’s Change
3.10
Today|||52-Week Range
9.15
-15.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues100.0K75.0K75.0K0.00
 
 
 
 
Depreciation And Amortization349.7K177.1K93.4K44.1K
 
 
 
 
 
 
Operating ExpensesGross Income-----18.4K-44.1K
 
 
 
General Expenses6.7M7.7M3.5M2.2M
 
 
 
 
 
Other Operating Expenses0.00258.7K181.4K-66.0K
 
 
 
 
Research And Development3.3M4.8M2.1M689.6K
 
 
 
 
 
Total Operating Expenses7.0M8.2M3.8M2.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.9M-8.1M-3.7M-2.1M
 
 
 
 
 
Extraordinary Credit0.00458.4K2.2M--
 
 
 
Extraordinary Charge-2.2M-10.4M-7.5M-2.9M
 
 
 
 
 
Interest Expense On Debt85.6K0.000.00265.2K
 
 
 
Other Expenses0.00-2.8K-533.00-1.6M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.2M-18.1M-8.9M-6.8M
 
 
 
 
 
Income Taxes0.000.00-680.0K-1.0M
 
 
 
Preferred Dividend-4.6M-838.9K-179.2K-397.9K
 
 
 
 
 
Net Income-9.2M-18.1M-8.3M-5.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS273.8K720.9K1.0M1.2M
 
 
 
 
 
Shares To Calculate EPS Diluted273.8K720.9K1.0M1.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$50.60-$26.20-$8.40-$5.40
 
 
 
 
 
EPS Diluted-$50.60-$26.20-$8.40-$5.40